STRS Ohio’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,600
Closed -$7K 2162
2023
Q1
$7K Hold
16,600
﹤0.01% 1911
2022
Q4
$19K Hold
16,600
﹤0.01% 1890
2022
Q3
$38K Buy
16,600
+13,300
+403% +$34.8K ﹤0.01% 1865
2022
Q2
$7K Buy
+3,300
New +$22.9K ﹤0.01% 2012

Other funds holding GRNA

STRS Ohio's GRNA Position: Q2 2023 in Review

STRS Ohio sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 16,600 shares — an estimated $7K sold.

STRS Ohio first reported a position in GRNA in Q2 2022 and held it in 4 quarters. The position peaked at $38K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

  • STRS Ohio reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
  • STRS Ohio sold 16,600 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $7K.
  • STRS Ohio first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 4 quarters.
  • STRS Ohio's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $38K in Q3 2022.
  • 48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.